Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.57 |
| ▸ | PPARG | P37231 | 7/20 | 0.57 |
| ▸ | PPARD | Q03181 | 7/20 | 0.57 |
| ▸ | PPARA | Q07869 | 7/20 | 0.57 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.57 |
| ▸ | TSHR | P16473 | 5/20 | 0.57 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.57 |
| ▸ | TLR2 | O60603 | 2/20 | 0.57 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.57 |
| ▸ | FABP4 | P15090 | 2/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.57 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.57 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.57 |
| ▸ | MEN1 | O00255 | 1/20 | 0.57 |
| ▸ | ESR1 | P03372 | 1/20 | 0.57 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.57 |
| ▸ | PDE4A | P27815 | 1/20 | 0.57 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.57 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6902315 | 1.00 | GPR84 (0.57) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL20377382 | 1.00 | GPR84 (0.57) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL20377393 | 1.00 | GPR84 (0.57) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL6751385 | 1.00 | — | — | |
| SCHEMBL20377396 | 1.00 | GPR84 (0.57) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL20377385 | 1.00 | GPR84 (0.57) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL20377398 | 1.00 | GPR84 (0.57) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL5360973 | 1.00 | GPR84 (0.57) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL9506597 | 1.00 | GPR84 (0.57) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL20377386 | 1.00 | GPR84 (0.57) | GPR84PPARGPPARDPPARAHDAC11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 109 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116234894-A | Suspension polymer compositions and methods of use thereof | 埃斯普投资有限公司 | 2023-06-06 | — | — | CN | claimed |
| EP-3810288-A1 | HAIR DYEING COMPOSITION COMPRISING AN OXIDATION DYE, A SCLEROGLUCAN GUM AND AN ASSOCIATIVE CELLULOSE POLYMER | L'OREAL (FR) | 2021-04-28 | — | — | EP | claimed |
| WO-2019243507-A1 | HAIR DYEING COMPOSITION COMPRISING AN OXIDATION DYE, A SCLEROGLUCAN GUM AND AN ASSOCIATIVE CELLULOSE POLYMER | L'OREAL (FR) | 2019-12-26 | — | — | WO | claimed |
| EP-2827829-B1 | PEG-FREE ANTIPERSPIRANT OIL-IN-WATER EMULSIONS HAVING IMPROVED FEEL | HENKEL AG & CO KGAA (DE) | 2017-02-08 | — | — | EP | claimed |
| US-20140301963-A1 | PEG-FREE ANTIPERSPIRANT OIL-IN-WATER EMULSIONS HAVING IMPROVED FEEL | HENKEL AG & CO. KGAA (DE) | 2014-10-09 | — | — | US | claimed |
| US-20120164087-A1 | Human Serum Albumin-Based Topical Ointment for Treatment of Acne, Psoriasis, Egfr-Induced Toxicity, Premature Skin Aging and Other Skin Conditions | NEW CENTURY PHARMACEUTICALS, INC. | 2012-06-28 | — | — | US | claimed |
| WO-2010124280-A2 | HUMAN SERUM ALBUMIN-BASED TOPICAL OINTMENT FOR TREATMENT OF ACNE, PSORIASIS, EGFR-INDUCED TOXICITY, PREMATURE SKIN AGING AND OTHER SKIN CONDITIONS | NEW CENTURY PHARMACEUTICALS, INC. (US) | 2010-10-28 | — | — | WO | claimed |
| US-6166078-A | Stable gelled composition with a high electrolyte content | L'OREAL (FR) | 2000-12-26 | — | — | US | claimed |
| US-5922764-A | COMPRISING A COSMETIC OR DERMATOLOGICAL AGENT INCLUDING HYDROXY ACIDS AND KETO ACIDS, CETYLHYDROXYETHYL CELLULOSE AND WATER, USE ON SKIN, HAIR, NAILS AS MOISTURIZER OR ANTI-AGING CREAM | L'OREAL (FR) | 1999-07-13 | — | — | US | claimed |
| EP-3810077-B1 | HAIR DYEING COMPOSITION COMPRISING AN OXIDATION DYE, A SCLEROGLUCAN GUM, AN ALCANOLAMINE AND A MINERAL ALKALINE AGENT | OREAL (FR) | 2024-04-17 | — | — | EP | disclosed |
| US-11884798-B2 | Film comprising hydrophobized cellulose fibers and oil | KAO CORPORATION (JP) | 2024-01-30 | — | — | US | disclosed |
| CN-117320685-A | Composition for skin protection comprising an antimicrobial agent and a (bio) -alkanediol | 西姆莱斯股份公司 | 2023-12-29 | — | — | CN | disclosed |
| CN-117015372-A | Method for making up keratin materials by applying a cover coating formed by the interaction of a polyhydric phenol with a hydrogen bonding compound and a cosmetic coating | 莱雅公司 | 2023-11-07 | — | — | CN | disclosed |
| US-20230346893-A1 | Methods and Compositions for Preventing or Minimizing Epithelial-Mesenchymal Transition | INNOVON PHARMACEUTIQUES INC. (CA) | 2023-11-02 | — | — | US | disclosed |
| US-6162448-A | Combination of a retinoid with a polyamine polymer | L'OREAL (FR) | 2000-12-19 | — | — | US | disclosed |
| US-5976516-A | N-DIHYDROXYPROPYL-SUPSTITUTED AMIDE WITH MELTING POINT FROM 0-50 DEGREES C. IMPARTS HAIR WITH SUPPLENESS AND IMPROVE THE TOUCH FEELING. | KAO CORPORATION (JP) | 1999-11-02 | — | — | US | disclosed |
| US-5922764-A | COMPRISING A COSMETIC OR DERMATOLOGICAL AGENT INCLUDING HYDROXY ACIDS AND KETO ACIDS, CETYLHYDROXYETHYL CELLULOSE AND WATER, USE ON SKIN, HAIR, NAILS AS MOISTURIZER OR ANTI-AGING CREAM | L'OREAL (FR) | 1999-07-13 | — | — | US | disclosed |
| US-5922764-A | COMPRISING A COSMETIC OR DERMATOLOGICAL AGENT INCLUDING HYDROXY ACIDS AND KETO ACIDS, CETYLHYDROXYETHYL CELLULOSE AND WATER, USE ON SKIN, HAIR, NAILS AS MOISTURIZER OR ANTI-AGING CREAM | L'OREAL (FR) | 1999-07-13 | — | — | US | disclosed |
| EP-0845256-A2 | Hair cosmetic compositions comprising an amide derivative | Kao Corporation (JP) | 1998-06-03 | — | — | EP | disclosed |
| EP-0664113-A2 | Hairdressing composition | KAO CORPORATION (JP) | 1995-07-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140301963-A1 | PEG-FREE ANTIPERSPIRANT OIL-IN-WATER EMULSIONS HAVING IMPROVED FEEL | GGCT, GLUL, PPARG | GPR84 217/4885PPARG 3/4885PPARD 60/4885 |
| US-20230346893-A1 | Methods and Compositions for Preventing or Minimizing Epithelial-Mesenchymal Transition | FABP6, HGFAC, VIM | GPR84 2878/4885PPARG 511/4885PPARD 1494/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.